1. Home
  2. PCRX vs MCB Comparison

PCRX vs MCB Comparison

Compare PCRX & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.41

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$94.00

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
MCB
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
PCRX
MCB
Price
$22.41
$94.00
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$30.25
$98.67
AVG Volume (30 Days)
359.7K
86.5K
Earning Date
04-30-2026
04-21-2026
Dividend Yield
N/A
1.13%
EPS Growth
107.44
11.64
EPS
0.07
2.92
Revenue
$541,533,000.00
$11,053,000.00
Revenue This Year
$6.78
$37.22
Revenue Next Year
$8.54
$14.75
P/E Ratio
$324.00
$31.95
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$64.55
52 Week High
$27.64
$97.84

Technical Indicators

Market Signals
Indicator
PCRX
MCB
Relative Strength Index (RSI) 41.76 57.82
Support Level $22.04 $86.38
Resistance Level $23.97 $97.29
Average True Range (ATR) 0.74 2.53
MACD -0.02 0.24
Stochastic Oscillator 21.43 71.06

Price Performance

Historical Comparison
PCRX
MCB

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

Share on Social Networks: